Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
621.77
657.56
1,008.26
1,045.84
1,208.58
1,105.36
2,011.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
621.77
657.56
1,008.26
1,045.84
1,208.58
1,105.36
2,011.32
Raw Material Cost
380.80
342.41
305.50
242.55
256.30
225.70
476.16
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
127.17
129.43
132.54
111.59
110.08
83.15
102.69
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.06
0.05
0.07
0.32
0.46
0.59
1.51
Selling and Distribution Expenses
764.81
154.34
326.70
504.23
549.86
544.27
948.97
Other Expenses
-2.55
0.59
3.13
3.86
7.46
9.71
1.81
Total Expenditure (Excl Depreciation)
1,247.33
632.16
796.11
897.31
991.29
950.79
1,547.38
Operating Profit (PBDIT) excl Other Income
-625.6
25.4
212.2
148.5
217.3
154.60000000000002
463.9
Other Income
14.03
2.93
36.35
86.59
114.45
77.57
95.84
Operating Profit (PBDIT)
-447.82
178.17
393.16
344.30
425.81
316.43
630.91
Interest
0.06
0.05
0.07
0.32
0.46
0.59
1.51
Exceptional Items
331.35
-172.29
205.21
19.49
114.03
176.41
13.70
Gross Profit (PBDT)
240.97
315.15
702.76
803.29
952.29
879.66
1,535.16
Depreciation
166.16
152.33
145.68
114.05
99.07
88.76
75.75
Profit Before Tax
-282.69
-146.51
452.63
249.42
440.32
403.50
567.35
Tax
70.06
-58.46
49.94
31.01
36.51
51.33
81.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-347.20
-74.07
416.69
234.40
425.94
364.71
486.78
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-347.20
-74.07
416.69
234.40
425.94
364.71
486.78
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.01
-1.22
-1.73
-6.06
-4.61
-3.26
-7.29
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-348.21
-75.29
414.96
228.34
421.33
361.45
479.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,181.40
5,572.45
5,800.62
5,468.08
5,311.50
4,974.61
4,808.20
Earnings per share (EPS)
-0.34
-0.07
0.41
0.23
0.41
0.35
0.47
Diluted Earnings per share
-0.34
-0.07
0.41
0.23
0.41
0.35
0.47
Operating Profit Margin (Excl OI)
-101.0%
3.48%
20.94%
13.74%
17.57%
13.58%
22.84%
Gross Profit Margin
-18.74%
0.88%
59.34%
34.75%
44.63%
44.53%
31.97%
PAT Margin
-55.84%
-11.26%
41.33%
22.41%
35.24%
32.99%
24.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -5.44% vs -34.78% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -362.42% vs -118.14% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -363.58% vs -50.90% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Beijing SL Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
621.77
0
621.77
Other Operating Income
0.00
0.00
0.00
Total Operating income
621.77
0
621.77
Raw Material Cost
380.80
0
380.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
127.17
0
127.17
Power Cost
0
0
0.00
Manufacturing Expenses
0.06
0
0.06
Selling and Distribution Expenses
764.81
0
764.81
Other Expenses
-2.55
0.00
-2.55
Total Expenditure (Excl Depreciation)
1,247.33
0
1,247.33
Operating Profit (PBDIT) excl Other Income
-625.56
0.00
-625.56
Other Income
14.03
0
14.03
Operating Profit (PBDIT)
-447.82
0
-447.82
Interest
0.06
0
0.06
Exceptional Items
331.35
0
331.35
Gross Profit (PBDT)
240.97
0
240.97
Depreciation
166.16
0
166.16
Profit Before Tax
-282.69
0
-282.69
Tax
70.06
0
70.06
Provisions and contingencies
0
0
0.00
Profit After Tax
-347.20
0
-347.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-347.20
0
-347.20
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.01
0
-1.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-348.21
0
-348.21
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,181.40
0
5,181.40
Earnings per share (EPS)
-0.34
0
-0.34
Diluted Earnings per share
-0.34
0
-0.34
Operating Profit Margin (Excl OI)
-101.00%
0%
0.00
-101.00%
Gross Profit Margin
-18.74%
0%
0.00
-18.74%
PAT Margin
-55.84%
0%
0.00
-55.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 62.18 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -5.44% vs -34.78% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -34.82 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -362.42% vs -118.14% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -46.18 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -363.58% vs -50.90% in Dec 2024
Annual - Interest
Interest 0.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -101.00%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
